Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial-Reference-Cited by-同舟云学术

Cetuximab plus chemotherapy in patients with advanced non-small-cell lung cancer (FLEX): an open-label randomised phase III trial

Published:2009-05 Issue:9674 Volume:373 Page:1525-1531
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Pirker Robert,Pereira Jose R,Szczesna Aleksandra,von Pawel Joachim,Krzakowski Maciej,Ramlau Rodryg,Vynnychenko Ihor,Park Keunchil,Yu Chih-Teng,Ganul Valentyn,Roh Jae-Kyung,Bajetta Emilio,O'Byrne Kenneth,de Marinis Filippo,Eberhardt Wilfried,Goddemeier Thomas,Emig Michael,Gatzemeier Ulrich

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

2. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis;Ardizzoni;J Natl Cancer Inst,2007

3. New molecularly targeted therapies for lung cancer;Sun;J Clin Invest,2007

4. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer;Cobo;J Clin Oncol,2007

5. Targeting the epidermal growth factor receptor for cancer therapy;Mendelsohn;J Clin Oncol,2002

Cited by 1188 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Genetic Analysis and Clinical Therapy in Lung Cancer: Current Advances and Future Directions;Cancers;2024-08-19

2. Rediscovering immunohistochemistry in lung cancer;Critical Reviews in Oncology/Hematology;2024-08

3. Comprehensive landscape of gastric cancer-targeted therapy and identification of CSNK2A1 as a potential target;Heliyon;2024-08

4. Distribution of EGFR fusions in 35,023 Chinese patients with solid tumors-the frequency, fusion partners and clinical outcome;World Journal of Surgical Oncology;2024-07-25

5. Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives;Frontiers in Oncology;2024-07-11